These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18989524)
1. Subclinical hyperthyroidism seems not to have a significant impact on systemic anticoagulation in patients with coumarin therapy. Bucerius J; Naubereit A; Joe AY; Ezziddin S; Biermann K; Risse J; Palmedo H; Oldenburg J; Biersack HJ Thromb Haemost; 2008 Nov; 100(5):803-9. PubMed ID: 18989524 [TBL] [Abstract][Full Text] [Related]
2. Impact of short-term hypothyroidism on systemic anticoagulation in patients with thyroid cancer and coumarin therapy. Bucerius J; Joe AY; Palmedo H; Reinhardt MJ; Biersack HJ Thyroid; 2006 Apr; 16(4):369-74. PubMed ID: 16646683 [TBL] [Abstract][Full Text] [Related]
3. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA; Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012 [TBL] [Abstract][Full Text] [Related]
4. Thyroid disease and haemostasis - a relationship with clinical implications? Squizzato A; Gerdes VE Thromb Haemost; 2008 Nov; 100(5):727-8. PubMed ID: 18989507 [No Abstract] [Full Text] [Related]
5. The necessity to assess anticoagulation status in elderly injured patients. Williams TM; Sadjadi J; Harken AH; Victorino GP J Trauma; 2008 Oct; 65(4):772-6; discussion 776-7. PubMed ID: 18849789 [TBL] [Abstract][Full Text] [Related]
6. Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis. Bucerius J; Ezziddin S; Brockmann H; Palmedo H; Biersack HJ Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):606-9. PubMed ID: 17943696 [TBL] [Abstract][Full Text] [Related]
7. Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial. Heemstra KA; Smit JW; Eustatia-Rutten CF; Heijboer AC; Frölich M; Romijn JA; Corssmit EP Clin Endocrinol (Oxf); 2006 Dec; 65(6):737-44. PubMed ID: 17121524 [TBL] [Abstract][Full Text] [Related]
8. Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants. Visser LE; Penning-van Beest FJ; Kasbergen AA; De Smet PA; Vulto AG; Hofman A; Stricker BH Clin Pharmacol Ther; 2002 Jun; 71(6):496-502. PubMed ID: 12087353 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation. Penning-van Beest FJ; van Meegen E; Rosendaal FR; Stricker BH Thromb Haemost; 2001 Aug; 86(2):569-74. PubMed ID: 11522005 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015 [TBL] [Abstract][Full Text] [Related]
11. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio. Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631 [TBL] [Abstract][Full Text] [Related]
12. INR comparison between the CoaguChek S and a standard laboratory method among patients with self-management of oral anticoagulation. Hentrich DP; Fritschi J; Müller PR; Wuillemin WA Thromb Res; 2007; 119(4):489-95. PubMed ID: 16765423 [TBL] [Abstract][Full Text] [Related]
13. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population. Nochowitz B; Shapiro NL; Nutescu EA; Cavallari LH Ann Pharmacother; 2009 Jul; 43(7):1165-72. PubMed ID: 19549747 [TBL] [Abstract][Full Text] [Related]
14. Minor oral surgery and interference with anticoagulation in patients taking warfarin: a retrospective study. Malden NJ; Santini A; Mather CI; Gardner A Br J Oral Maxillofac Surg; 2007 Dec; 45(8):645-7. PubMed ID: 17683833 [TBL] [Abstract][Full Text] [Related]
15. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. Visser LE; Bleumink GS; Trienekens PH; Vulto AG; Hofman A; Stricker BH Br J Haematol; 2004 Oct; 127(1):85-9. PubMed ID: 15384981 [TBL] [Abstract][Full Text] [Related]
16. Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation. Marco F; Gutiérrez JI; Orkolaga K; Márquez JA; Ojínaga MJ; de Zárate IO; de Heredia JM Blood Coagul Fibrinolysis; 2006 Sep; 17(6):509-12. PubMed ID: 16905959 [TBL] [Abstract][Full Text] [Related]
17. INR variability in atrial fibrillation: a risk model for cerebrovascular events. Amouyel P; Mismetti P; Langkilde LK; Jasso-Mosqueda G; Nelander K; Lamarque H Eur J Intern Med; 2009 Jan; 20(1):63-9. PubMed ID: 19237095 [TBL] [Abstract][Full Text] [Related]
18. [Update of INR-selfmonitoring]. Völler H; Braun S Hamostaseologie; 2008 Oct; 28(4):231-3. PubMed ID: 18836650 [TBL] [Abstract][Full Text] [Related]
19. Discrepancies between medication records of anticoagulation clinics and pharmacy records. Schalekamp T; Smit C; van Geest-Daalderop JH; de Vries-Goldschmeding H; de Boer A Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):823-8. PubMed ID: 16835939 [TBL] [Abstract][Full Text] [Related]
20. Performance evaluation of a new small-volume coagulation monitor: the SmartCheck INR system. Gardiner C; Longair I; Hills J; Cohen H; Mackie IJ; Machin SJ Am J Clin Pathol; 2008 Mar; 129(3):500-4. PubMed ID: 18285276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]